Are there differences in acute phase inflammation markers regarding the type of heart failure?

• Main Authors: Jaime Agüero-Ramón-Llin, Antonio Salvador-Sanz, Luis Martínez-Dolz, Vicenta Martínez-Sales, Virtudes Vila-Liante, Edelmiro Reganon-Salvador, Ignacio J. Sanchez-Lazaro, Luis Almenar-Bonet
• Format: Article
• Language: English
• Published: Touch Medical Media 2011-09-01
• Series: Heart International
• Subjects: heart failure, inflammation
• Online Access: http://www.pagepress.org/journals/index.php/hi/article/view/2519

This study aimed to determine if there are differences in inflammatory markers in the acute phase between systolic heart failure and heart failure with preserved systolic function. One hundred and thirty-one patients with acute heart failure were recruited consecutively. At admission, plasma fibrinogen, Creactive protein, sialic acid, von Willebrand factor, vascular endothelial growth factor, interleukin-6 and NTproBNP were all evaluated. If the ejection fraction was 45% or over patients were included in the HF-PSF group; the remaining patients were included in the SHF group. The HF-PSF patients were older (72±10 vs 63±12 years, P<0.001), presented a higher rate of atrial fibrillation (56.1 vs 21.3%, P<0.001), and had a lower rate of hemoglobin (12.2±2 vs 13.3±2.1 g/dL, P<0.01). No significant differences were observed in the inflammation markers analyzed among SHF and HFPSF groups. In the acute phase of heart failure there is a marked elevation of inflammatory markers but there are no differences in the inflammatory markers analyzed between the two different types of heart failure